Literature DB >> 1825448

The clearance of immune complexes from the circulation of man and other primates.

L A Hebert1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1825448     DOI： 10.1016/s0272-6386(12)80488-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  16 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

2.  Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.

Authors:  J E Teixeira; R Martinez; L M Câmara; J E Barbosa
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

3.  SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleen.

Authors:  Javier Gordon Ogembo; Danny A Milner; Keith G Mansfield; Scott J Rodig; George F Murphy; Jeffery L Kutok; Geraldine S Pinkus; Joyce D Fingeroth
Journal:  J Immunol       Date:  2012-04-04       Impact factor: 5.422

4.  Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Authors:  Celene M O S Alves; Cleni M Marzocchi-Machado; Paulo Louzada-Junior; Ana Elisa C S Azzolini; Ana Cristina M Polizello; Ivan F de Carvalho; Yara M Lucisano-Valim
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

5.  Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

Authors:  Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Daniel J Birmingham; Brad H Rovin
Journal:  Theor Biol Med Model       Date:  2010-05-17       Impact factor: 2.432

6.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

7.  A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding.

Authors:  Daniel J Birmingham; Fawzi Irshaid; Katherine F Gavit; Haikady N Nagaraja; C Yung Yu; Brad H Rovin; Lee A Hebert
Journal:  Mol Immunol       Date:  2007-04-30       Impact factor: 4.407

8.  Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.

Authors:  D Di Bona; G Montalto; L Clemenza; F Bascone; P Accardo; D Bellavia; A Craxì; M Brai
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 9.  Complement regulation in renal disease models.

Authors:  Abhijit Naik; Shweta Sharma; Richard J Quigg
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

10.  The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.

Authors:  Jessy J Alexander; Lee Chaves; Anthony Chang; Richard J Quigg
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.